Literature DB >> 29020266

Propionibacterium avidum: A Virulent Pathogen Causing Hip Periprosthetic Joint Infection.

Yvonne Achermann1, Jared Liu2, Reinhard Zbinden3, Patrick O Zingg4, Alexia Anagnostopoulos1, Emma Barnard2, Reto Sutter5, Huiying Li2, Andrew McDowell6, Annelies S Zinkernagel1.   

Abstract

Background: Propionibacteria are important members of the human skin microbiota, but are also opportunistic pathogens associated with periprosthetic joint infection (PJI). While the role of Propionibacterium acnes in PJI has been widely described, insight into the capacity of Propionibacterium avidum to cause PJI is limited.
Methods: An unusual cluster of 4 hip PJIs caused by P. avidum in one orthopedic center in 2015 prompted us to retrospectively identify and analyze clinical data related to previous P. avidum PJI cases (1997-2015). We also characterized the hemolytic and biofilm-producing capacity of our 4 clinical P. avidum strains isolated in 2015, and investigated their phylogenetic relationships by whole-genome sequencing.
Results: We retrospectively identified 13 P. avidum PJIs, with the majority being hip-related infections (n = 11). Preoperative synovial fluid cultures were P. avidum positive in 63.6% of cases. Six of 12 patients (50%) with available case histories were treated with an exchange of the prosthesis. In all but 1 of the 6 patients treated with debridement-retention of the prosthesis, treatment failed, thus requiring a 2-stage revision. The isolated P. avidum strains showed a more pronounced hemolytic activity, but a similar biofilm-forming ability when compared to P. acnes. Whole-genome sequencing identified 2 phylogenetic clusters highly related to P. avidum PJI strains isolated in Sweden. Conclusions: We describe the largest series of P. avidum PJI predominantly located in the hip. Phylogenetic similarity of our P. avidum strains to PJI strains isolated elsewhere suggests that these invasive lineages may be common.
© The Author 2017. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Cutibacterium avidum; Propionibacterium avidum; hip; periprosthetic joint infection; whole-genome sequencing

Mesh:

Year:  2018        PMID: 29020266      PMCID: PMC5850018          DOI: 10.1093/cid/cix665

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  37 in total

Review 1.  Propionibacterium acnes: from commensal to opportunistic biofilm-associated implant pathogen.

Authors:  Yvonne Achermann; Ellie J C Goldstein; Tom Coenye; Mark E Shirtliff
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

2.  Prosthetic valve with infective endocarditis caused by Propionibacterium avidum. A case report.

Authors:  Jose Loureiro-Amigo; Silvia Pons; Montserrat Sierra; Yolanda Meije
Journal:  Enferm Infecc Microbiol Clin       Date:  2016-10-12       Impact factor: 1.731

3.  Immunoproteomic Identification of In Vivo-Produced Propionibacterium acnes Proteins in a Rabbit Biofilm Infection Model.

Authors:  Yvonne Achermann; Bao Tran; Misun Kang; Janette M Harro; Mark E Shirtliff
Journal:  Clin Vaccine Immunol       Date:  2015-02-18

4.  Propionibacterium acnes: an underestimated etiology in the pathogenesis of osteoarthritis?

Authors:  Ofer Levy; Shabnam Iyer; Ehud Atoun; Noel Peter; Nir Hous; Dave Cash; Fawaz Musa; A Ali Narvani
Journal:  J Shoulder Elbow Surg       Date:  2012-09-13       Impact factor: 3.019

5.  Cell wall composition and deoxyribonucleic acid similarities among the anaerobic coryneforms, classical propionibacteria, and strains of Arachnia propionica.

Authors:  J L Johnson; C S Cummins
Journal:  J Bacteriol       Date:  1972-03       Impact factor: 3.490

Review 6.  Prosthetic joint infection.

Authors:  Aaron J Tande; Robin Patel
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132

7.  Hemolysis as a clinical marker for propionibacterium acnes orthopedic infection.

Authors:  Scott R Nodzo; Donald W Hohman; John K Crane; Thomas R Duquin
Journal:  Am J Orthop (Belle Mead NJ)       Date:  2014-05

8.  Identification of Propionibacterium avidum from a breast abscess: an overlooked etiology of clinically significant infections.

Authors:  A Kritikos; M Pagin; O Borens; C Voide; C Orasch
Journal:  New Microbes New Infect       Date:  2014-12-19

9.  Pan-genome and comparative genome analyses of propionibacterium acnes reveal its genomic diversity in the healthy and diseased human skin microbiome.

Authors:  Shuta Tomida; Lin Nguyen; Bor-Han Chiu; Jared Liu; Erica Sodergren; George M Weinstock; Huiying Li
Journal:  mBio       Date:  2013-04-30       Impact factor: 7.867

10.  Body mass and weight thresholds for increased prosthetic joint infection rates after primary total joint arthroplasty.

Authors:  Anne Lübbeke; Matthieu Zingg; Diemlan Vu; Hermes H Miozzari; Panayiotis Christofilopoulos; Ilker Uçkay; Stephan Harbarth; Pierre Hoffmeyer
Journal:  Acta Orthop       Date:  2016-01-05       Impact factor: 3.717

View more
  10 in total

Review 1.  Clinical and Biological Features of Cutibacterium (Formerly Propionibacterium) avidum, an Underrecognized Microorganism.

Authors:  Stéphane Corvec
Journal:  Clin Microbiol Rev       Date:  2018-05-30       Impact factor: 26.132

2.  Antimicrobial photodynamic therapy against Propionibacterium acnes biofilms using hypericin (Hypericum perforatum) photosensitizer: in vitro study.

Authors:  Rosmeire Aparecida Barroso; Ricardo Navarro; Carla Roberta Tim; Lucas de Paula Ramos; Luciane Dias de Oliveira; Ângela Toshie Araki; Karina Gonzales Camara Fernandes; Daniela Macedo; Lívia Assis
Journal:  Lasers Med Sci       Date:  2020-10-21       Impact factor: 3.161

3.  Simultaneous Propionibacterium avidum and Propionibacterium acnes Chronic Periprosthetic Hip Joint Infection: A Case Report.

Authors:  Stefano Gussago; Luigia Elzi; Michele Arigoni; Cristiana Poroli Bastone; Mauro N Molina
Journal:  Cureus       Date:  2021-12-28

4.  Revealing antimicrobial resistance in stormwater with MinION.

Authors:  Maciej Białasek; Aleksandra Miłobędzka
Journal:  Chemosphere       Date:  2020-06-17       Impact factor: 7.086

5.  Orthopedic implant-associated infections caused by Cutibacterium spp. - A remaining diagnostic challenge.

Authors:  Nora Renz; Stasa Mudrovcic; Carsten Perka; Andrej Trampuz
Journal:  PLoS One       Date:  2018-08-20       Impact factor: 3.240

6.  Surgical Approach to Total Hip Arthroplasty Affects the Organism Profile of Early Periprosthetic Joint Infections.

Authors:  Daniel B Buchalter; Greg M Teo; David J Kirby; Vinay K Aggarwal; William J Long
Journal:  JB JS Open Access       Date:  2020-11-25

7.  Cutibacterium avidum resists surgical skin antisepsis in the groin-a potential risk factor for periprosthetic joint infection: a quality control study.

Authors:  Steven M Maurer; Laura Kursawe; Stefan Rahm; Julia Prinz; Annelies S Zinkernagel; Annette Moter; Stefan P Kuster; Reinhard Zbinden; Patrick O Zingg; Yvonne Achermann
Journal:  Antimicrob Resist Infect Control       Date:  2021-02-01       Impact factor: 4.887

8.  True infection or contamination in patients with positive Cutibacterium blood cultures-a retrospective cohort study.

Authors:  Jolin Boman; Bo Nilson; Torgny Sunnerhagen; Magnus Rasmussen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2022-05-25       Impact factor: 5.103

9.  Differential microbiological spectrum and resistance pattern in periprosthetic hip joint infections: a matched-cohort analysis comparing direct anterior versus lateral approach.

Authors:  Alexander Aichmair; Bernhard J H Frank; Gabriel Singer; Sebastian Simon; Martin Dominkus; Jochen G Hofstaetter
Journal:  BMC Musculoskelet Disord       Date:  2022-01-19       Impact factor: 2.362

Review 10.  The role of biofilm formation in the pathogenesis and antimicrobial susceptibility of Cutibacterium acnes.

Authors:  Tom Coenye; Karl-Jan Spittaels; Yvonne Achermann
Journal:  Biofilm       Date:  2021-12-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.